FDA approves clonidine hydrochloride to treat ADHD in patients 6 years and up
The once daily extended-release oral suspension with nighttime dosing is approved to treat ADHD as a monotherapy or as an adjunctive therapy to approved CNS stimulant medications.
Peanut consumption through 5 years of age provides lasting tolerance into adolescence
Peanut consumption starting in infancy resulted in lasting tolerance into adolescence.
Early adolescents with complex congenital heart disease have higher stress markers
Findings indicate that chronically high stress markers could have a role in the development of EF impairments in early adolescents with cCHD.
Study: Ultraprocessed food increases cardiovascular risk in children
A recent study suggests that high ultraprocessed food consumption in preschool children is linked to increased cardiometabolic risk factors.
Adolescent borderline personality disorder linked to high risk of ADHD, schizophrenia in later years
New international findings show BPD diagnosis in teenaged years may be a critical indicator of subsequent mental disorder into young adulthood.
Weekly review: Teen caffeine intake, GLP-1 prescriptions, and more
Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Adolescent GLP-1 prescriptions increased 6-fold from 2020 to 2023
Drugs like semaglutide and liraglutide were dispensed at unprecedented increased rates for adolescents and young adults over a span of just 4 years.
Depression not increased by gender identity changes in adolescents
Approximately 1 in 5 youths who identify as a sexual gender minority will undergo a gender identity change in their adolescence; however, such changes do not appear to impact their mental health.
Integrating behavioral health within primary care settings
Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the latest issue of Contemporary Pediatrics and how these articles can be utilized in the everyday practice of PNPs.
Sun burn consequences and sunscreen recommendations for children
Wendy Ripple, MD, provides suggestions for sunscreens in the pediatric population.
Prenatal opioid exposure could have long-term impact on immune system
In the retrospective, population-based cohort study, the investigators used linked administrative health records of all children born in Western Australia between January 1, 2003 and December 31, 2018 (n = 401,462).
Weekly review: FDA news, hypertension studies, and more
Children with hypertension at higher risk of associated major adverse cardiac events
Children with hypertension were at an increased risk of stroke, congestive heart failure, and other major adverse cardiac events compared to non-hypertensive individuals.
Practical reminders for sunscreen recommendations, sun safety as summer approaches
As children head outside for summer, providers can remind parents of some staple sun safety tips.
FDA expands label for lipid injectable emulsion to preterm and term neonates
Approximately 40% of patients who receive PN in the United States as an intravenous source of nourishment are under 18 years of age.
T2D risk increased with increased HbA1c levels among adolescents with overweight, obesity
Investigators found that higher baseline HbA1c was associated with greater T2D risk.
Study lays groundwork for potential vaccine customized for children with recurrent eczema flares
These data from investigators at Trinity College Dublin highlighted the immune response mechanisms visible in children with atopic dermatitis.
Did hypertension guidelines change practice patterns in primary care?
Even 6 years after publication, the investigative team stated it is unknown if the recommendations have led to changes in primary care.
Iron supplements ineffective at improving psychomotor development in breastfed babies
“We found no statistically significant effect of early iron supplementation on developmental scores at 24 and 36 months,” wrote the study investigators.
FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years
The federal agency has accepted the sBLA for Priority Review designation, with a target action date of September 15, 2024.
FDA approves ALTUVIIIO updated label for bleed protection in children with hemophilia
The extended label approval is based on full evidence from the XTEND-Kids study.
Weekly review: Profound genetic deafness gene therapy, measles increases, and more
HPV vaccination coverage of US-children aged 9-17 years in 2022
According to the report authors, girls were more likely to receive 1 or more HPV vaccine doses compared to boys (42.9% vs 34.6%).
How to talk to your teenaged patient about pregnancy and contraception
As teenagers become sexually active, are they fully educated on contraception and pregnancy?
HCPs can play an important role in addressing the US infant formula shortage
When breastfeeding is not an option, caregivers will turn to infant formulas to meet their child’s nutritional needs.
Nirsevimab reservation program enrollment deadline extended
The program allows participants to reserve doses and be eligible for priority shipping, among other benefits.
Sun-safe practices in different pediatric patients
Caregivers and parents should feel empowered to protect their children with sun-safe practices that include sunscreen, sun-protective clothing, and sun-safe activities.
Emergency department serves as equitable location for influenza vaccine delivery
Courtney Nelson, MD, highlights the session she presented at the PAS annual meeting discussing racial and ethnic disparities for influenza vaccine delivery.
DB-OTO improved hearing to normal in child with profound genetic deafness
Data from the ongoing phase 1/2 CHORD trial was presented at the ASGCT annual conference.
Child welfare: Now that we know better, let’s do better
Improvement in access to mental health resources for children would decrease vicarious trauma of foster parents and social workers via improved living and working conditions.